Megan Undeberg*
Cancer, a relentless adversary that spares no age group, poses a particularly poignant challenge when it affects children. Pediatric cancer, while comparatively rare, is devastating not only due to the disease itself but also because it disrupts the lives of young patients during crucial stages of development. In recent years, the landscape of pediatric chemotherapy has witnessed significant innovations, ushering in a new era of hope and progress. These innovations not only focus on enhancing survival rates but also prioritize the quality of life for young patients, marking a profound shift in the way we approach pediatric oncology.
Partagez cet article
English 
Spanish 
Chinese 
Russian 
German 
Japanese 
Portuguese 
Hindi 